Metformin may curb depression risk in diabetes patients

12/2/2012 | Diabetes.co.uk (U.K.)

Type 2 diabetes patients who were on metformin treatment had a reduced risk of mood disorders such as depression, as well as Parkinson's disease and dementia, especially if sulfonylurea drugs were used as an add-on therapy, a study from Taiwan showed. The results appear in BMC Medicine.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID